Company Overview: ZIOP

Upcoming Projects (ZIOP)

Don’t see a project related to the company you care about? Create your own!

Expired Projects (ZIOP)

Discussing Ziopharm’s Sleeping Beauty TCR-T platform targeting neoantigens in solid tumors
Ticker: ZIOP
Execute By: Mar 31, 2020
Where does ZioPharma's "Sleeping Beauty" technology stand after the most recent Clinical Hold on the company's "very-rapidly manufactured CD19-specific T cells"?
Ticker: ZIOP
Execute By: Aug 10, 2018

Upcoming & Overdue Catalysts (ZIOP)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (ZIOP)

Ziopharm (ZIOP) estimates completion of Phase 1 study of Autologous CD19-specific T Cells Infusion in patients with Lymphoma in late 2018
Tickers: ZIOP, XON
Occurred on: Aug 08, 2019
Ziopharm (ZIOP) to complete Phase 1 trial of Allogeneic CD19-Specific T Cells From Peripheral Blood in HSCT patients by December 2016 - On Hold
Tickers: ZIOP, XON
Occurred on: Jun 18, 2018
ZIOPHARM (ZIOP) to launch Phase 1 clinical trial of off-the-shelf primary NK cells for investigational therapy of acute myeloid leukemia in 2016
Tickers: ZIOP, XON
Occurred on: Nov 06, 2017
ZIOPHARM (ZIOP) to complete Phase 1/2 trial of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer by August 2017
Ticker: ZIOP
Occurred on: Sep 18, 2017
ZIOPHARM (ZIOP) to launch Phase 1 study of a viral-based CAR T-cell therapy for myeloid malignancies in 2016
Tickers: ZIOP, XON
Occurred on: Jun 28, 2017
ZIOPHARM (ZIOP) to finish Phase 1 study of Ad-RTS-hIL-12 with Veledimex in Subjects With Glioblastoma or Malignant Glioma in December 2016
Ticker: ZIOP
Occurred on: Nov 17, 2016
Ziopharm (ZIOP) Announces Interim Phase 1 Results Assessing Ad-RTS-hIL-12 + Veledimex in Patients with Recurrent Brain Cancer at the 21st Annual Scientific Meeting of the Society for Neuro-Oncology
Ticker: ZIOP
Occurred on: Nov 17, 2016
ZIOPHARM (ZIOP) Presents Data Demonstrating Activation of Anti-Tumor Immune Response Using Ad-RTS-hIL-12 in Patients with Advanced Breast Cancer
Ticker: ZIOP
Occurred on: Oct 10, 2016
ZIOPHARM Reports 2 Patient Deaths in its Phase I Study of Gene Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer
Ticker: ZIOP
Occurred on: Jul 15, 2016
ZIOPHARM Announces Plans for Phase I Clinical Trial with CD33 CAR-T Cell Therapy Targeting Acute Myeloid Leukemia
Ticker: ZIOP
Occurred on: Jul 12, 2016
FDA has removed the clinical hold on the Phase II clinical trial of JCAR015 (known as the “ROCKET” trial) in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (r/r ALL)
Tickers: JUNO, CLLS, KITE, BLUE, ZIOP
Occurred on: Jul 12, 2016
ZIOPHARM (ZIOP) to launch Phase 1 trial in patients with glioblastoma using the combination of Ad-RTS-IL-12 + veledimex and a selected checkpoint inhibitor in 2016
Ticker: ZIOP
Occurred on: Jun 27, 2016
ZIOPHARM (ZIOP) to report updated results on Ad-RTS-hIL-12 and veledimex at ASCO 2016
Ticker: ZIOP
Occurred on: Jun 07, 2016
ZIOPHARM (ZIOP) to present data from preclinical studies of Ad-RTS-IL-12 + veledimex combined with checkpoint inhibitors in glioblastoma mouse models at American Society of Gene and Cell Therapy (ASGCT)
Ticker: ZIOP
Occurred on: May 18, 2016
Leukemia Research presented at American Association for the Advancement of Science (AAAS) leads to boost for CAR-T developers
Tickers: BLUE, KITE, CLLS, ZIOP, JUNO, BLCM, CYAD, ADAP
Occurred on: Feb 16, 2016
ZIOPHARM Announces First Patient Enrolled in Phase 1 Study of Second Generation Non-Viral CD19-Specific CAR T-Cell Therapy for Advanced Lymphoid Malignancies
Ticker: ZIOP
Occurred on: Feb 09, 2016

Strategic Initiatives (ZIOP)

ZioPharm announces potential point-of-care (POC) manufacturing of CAR-T cells using its Sleeping Beauty system
Ticker: ZIOP
Announcement Date: Feb 12, 2018

ZIOP Overview